CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
1-Year Return
18.35%
This Quarter Return
+4.26%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$5.67B
AUM Growth
+$449M
(+8.6%)
Cap. Flow
+$364M
Cap. Flow
% of AUM
6.41%
Top 10 Holdings %
Top 10 Hldgs %
62.73%
Holding
134
New
17
Increased
54
Reduced
18
Closed
9
Top Buys
| 1 |
Amazon
AMZN
|
$244M |
| 2 |
TSMC
TSM
|
$41.5M |
| 3 |
Alibaba
BABA
|
$26.9M |
| 4 |
HDFC Bank
HDB
|
$26.9M |
| 5 |
Visa
V
|
$25.8M |
Top Sells
| 1 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
$137M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$37M |
| 3 |
Meta Platforms (Facebook)
META
|
$30.4M |
| 4 |
Pfizer
PFE
|
$14.9M |
| 5 |
UnitedHealth
UNH
|
$9.86M |
Sector Composition
| 1 | Financials | 24.53% |
| 2 | Healthcare | 24.41% |
| 3 | Consumer Discretionary | 17.31% |
| 4 | Communication Services | 13.45% |
| 5 | Consumer Staples | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
26
DELISTED
Allergan plc
AGN
| $27.1M | 0.48% |
117,542
| – | – |
|
|
SHPG
27
DELISTED
Shire pic
SHPG
| $25.2M | 0.44% |
130,174
+23,680
| +22% | +$4.59M |
|
|
28
Pfizer
PFE
$139B
| $24M | 0.42% |
747,196
-463,760
| -38% | -$14.9M |
|
|
CEMP
29
DELISTED
Cempra, Inc.
CEMP
| $21.7M | 0.38% |
896,800
+166,170
| +23% | +$4.02M |
|
30
Thermo Fisher Scientific
TMO
$181B
| $21.3M | 0.38% |
134,152
+60,512
| +82% | +$9.62M |
|
31
Merck
MRK
$209B
| $21.1M | 0.37% |
354,640
+140,432
| +66% | +$8.36M |
|
32
Centene
CNC
$14.1B
| $18.7M | 0.33% |
557,120
| – | – |
|
33
BioMarin Pharmaceuticals
BMRN
$11B
| $17.8M | 0.31% |
192,185
+84,610
| +79% | +$7.83M |
|
34
Cigna
CI
$80.7B
| $17M | 0.3% |
130,300
+25,000
| +24% | +$3.26M |
|
|
HZNP
35
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $13.6M | 0.24% |
747,600
+82,600
| +12% | +$1.5M |
|
|
36
Alphabet (Google) Class A
GOOGL
$2.75T
| $13.1M | 0.23% |
326,020
-921,400
| -74% | -$37M |
|
37
Glaukos
GKOS
$5.26B
| $12.8M | 0.23% |
340,000
+265,000
| +353% | +$10M |
|
38
Teva Pharmaceuticals
TEVA
$21.4B
| $12.2M | 0.21% |
265,000
| – | – |
|
39
Jazz Pharmaceuticals
JAZZ
$7.87B
| $11.4M | 0.2% |
93,587
+7,398
| +9% | +$899K |
|
40
HCA Healthcare
HCA
$96.5B
| $11M | 0.19% |
145,075
| – | – |
|
41
Nike
NKE
$111B
| $10.6M | 0.19% |
201,880
| – | – |
|
42
AbbVie
ABBV
$377B
| $6.78M | 0.12% |
107,500
| – | – |
|
|
ESRX
43
DELISTED
Express Scripts Holding Company
ESRX
| $6.58M | 0.12% |
93,301
-75,000
| -45% | -$5.29M |
|
44
Zimmer Biomet
ZBH
$20.8B
| $6.5M | 0.11% |
+51,500
| New | +$6.5M |
|
45
DaVita
DVA
$9.74B
| $6.32M | 0.11% |
95,691
| – | – |
|
|
EGRX
46
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.84M | 0.1% |
83,407
-14,000
| -14% | -$980K |
|
47
Exelixis
EXEL
$10B
| $5.76M | 0.1% |
+450,000
| New | +$5.76M |
|
48
Bausch Health
BHC
$2.65B
| $5.51M | 0.1% |
224,461
+63,000
| +39% | +$1.55M |
|
|
ALXN
49
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $5.46M | 0.1% |
44,561
+2,600
| +6% | +$319K |
|
50
Ultragenyx Pharmaceutical
RARE
$3.01B
| $5.36M | 0.09% |
75,500
+14,500
| +24% | +$1.03M |
|